Canada NewsWire
TORONTO, March 3, 2016
TORONTO, March 3, 2016 /CNW/ - George Weston Limited (TSX: WN) ("GWL" or the "Company") today announced its consolidated unaudited results for the 12 weeks ended December 31, 2015.
GWL's 2015 Annual Report includes the Company's audited annual consolidated financial statements and Management's Discussion and Analysis ("MD&A") for the fiscal year ended December 31, 2015. The 2015 Annual Report has been filed with SEDAR and is available at sedar.com and in the Investor Centre section of the Company's website at weston.ca.
As a result of the Company's reporting calendar, the fourth quarter and full year 2014 included an extra week of operations (the "53rd week") compared to 2015.
"We are pleased with George Weston Limited's performance in 2015 as both of the Company's operating segments continued to execute on their strategic priorities. Progress in 2015 reinforces our confidence that the Company is well-positioned for stable, long term growth and profitability", said W. Galen Weston, Executive Chairman, George Weston Limited.
2015 FOURTH QUARTER HIGHLIGHTS | ||||||||||||||||||
(unaudited) | Quarters | Ended | Years | Ended | ||||||||||||||
($ millions except where otherwise indicated) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | ||||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | Change | (52 weeks) | (53 weeks) | Change | ||||||||||||
Sales | $ | 11,248 | $ | 11,734 | (4.1)% | $ | 46,894 | $ | 43,918 | 6.8% | ||||||||
Sales excluding 53rd week | $ | 11,248 | $ | 10,925 | 3.0% | $ | 46,894 | $ | 43,109 | 8.8% | ||||||||
Adjusted EBITDA(1) | $ | 946 | $ | 1,022 | (7.4)% | $ | 3,826 | $ | 3,530 | 8.4% | ||||||||
Adjusted EBITDA(1) excluding 53rd week | $ | 946 | $ | 945 | 0.1% | $ | 3,826 | $ | 3,453 | 10.8% | ||||||||
Adjusted EBITDA margin(1) | 8.4% | 8.7% | 8.2% | 8.0% | ||||||||||||||
Net earnings attributable to shareholders | ||||||||||||||||||
of the Company | $ | 148 | $ | 161 | (8.1)% | $ | 527 | $ | 126 | 318.3% | ||||||||
Net earnings available to common | ||||||||||||||||||
shareholders of the Company | $ | 138 | $ | 151 | (8.6)% | $ | 483 | $ | 82 | 489.0% | ||||||||
Net earnings available to common shareholders | ||||||||||||||||||
of the Company excluding 53rd week(i) | $ | 138 | $ | 122 | 13.1% | $ | 483 | $ | 53 | 811.3% | ||||||||
Adjusted net earnings available to common | ||||||||||||||||||
shareholders of the Company(1) | $ | 183 | $ | 202 | (9.4)% | $ | 717 | $ | 680 | 5.4% | ||||||||
Adjusted net earnings available to common | ||||||||||||||||||
shareholders of the Company(1) excluding 53rd week(i) | $ | 183 | $ | 173 | 5.8% | $ | 717 | $ | 651 | 10.1% | ||||||||
Basic net earnings per common share ($) | $ | 1.08 | $ | 1.18 | (8.5)% | $ | 3.78 | $ | 0.64 | 490.6% | ||||||||
Basic net earnings per common share ($) | ||||||||||||||||||
excluding 53rd week(i) | $ | 1.08 | $ | 0.95 | 13.7% | $ | 3.78 | $ | 0.41 | 822.0% | ||||||||
Adjusted basic net earnings per common share(1) ($) | $ | 1.43 | $ | 1.58 | (9.5)% | $ | 5.61 | $ | 5.32 | 5.5% | ||||||||
Adjusted basic net earnings per common share(1) ($) | ||||||||||||||||||
excluding 53rd week(i) | $ | 1.43 | $ | 1.35 | 5.9% | $ | 5.61 | $ | 5.09 | 10.2% | ||||||||
(i) |
The impact of the 53rd week on net earnings available to common
shareholders of the Company is estimated based on applying the 2014 effective tax rate to the 53rd week net earnings before income taxes of $77 million, net of non-controlling interest. |
Pavi Binning, President and Chief Executive Officer, George Weston Limited, commented that "George Weston Limited's fourth quarter results came in as expected. Loblaw continued to execute on its strategic priorities, delivering positive same-store sales and stable margins amidst a competitive retail environment and continued pressures from healthcare reform. Weston Foods delivered sales growth and financial performance in line with expectations as it continued to invest in the business and execute on its priorities."
CONSOLIDATED RESULTS OF OPERATIONS
The 53rd week of 2014 resulted in an additional $809 million of sales,
$77 million of operating income, and estimated impacts on net earnings
available to common shareholders and basic net earnings per common
share of $29 million and $0.23 per share, respectively.
Adjusted net earnings available to common shareholders of the Company(1) decreased by $19 million ($0.15 per common share) to $183 million ($1.43 per common share) in the fourth quarter of 2015 compared to the same period in 2014. The decrease included the negative year-over-year impact of the 53rd week of $29 million ($0.23 per common share). Excluding the 53rd week, adjusted net earnings available to common shareholders of the Company(1) increased $10 million ($0.08 per common share) primarily due to:
Net earnings available to common shareholders of the Company decreased by $13 million ($0.10 per common share) to $138 million ($1.08 per common share) in the fourth quarter of 2015 compared to the same period in 2014. The decrease included the negative year-over-year impact of the 53rd week. Excluding the 53rd week, net earnings available to common shareholders of the Company increased $16 million ($0.13 per common share). In addition to the items described above, the increase in net earnings available to common shareholders of the Company included the favourable year-over-year net impact of the following significant items:
REPORTABLE OPERATING SEGMENTS
Weston Foods Segment Results | |||||||||||||||||
(unaudited) | Quarters | Ended | Years | Ended | |||||||||||||
($ millions except where otherwise indicated) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | Change | (52 weeks) | (53 weeks) | Change | |||||||||||
Sales | $ | 527 | $ | 469 | 12.4% | $ | 2,144 | $ | 1,923 | 11.5% | |||||||
Sales excluding 53rd week | $ | 527 | $ | 438 | 20.3% | $ | 2,144 | $ | 1,892 | 13.3% | |||||||
Adjusted EBITDA(1) | $ | 67 | $ | 74 | (9.5)% | $ | 285 | $ | 311 | (8.4)% | |||||||
Adjusted EBITDA(1) excluding 53rd week | $ | 67 | $ | 68 | (1.5)% | $ | 285 | $ | 305 | (6.6)% | |||||||
Adjusted EBITDA margin(1) | 12.7% | 15.8% | 13.3% | 16.2% | |||||||||||||
Depreciation and amortization(i) | $ | 25 | $ | 17 | 47.1% | $ | 94 | $ | 70 | 34.3% | |||||||
(i) |
Depreciation and amortization in the fourth quarter of 2015 and
year-to-date includes $6 million (2014 - nil) and $11 million (2014 - nil), respectively, of accelerated depreciation recorded as restructuring and other charges. |
Sales Weston Foods sales in the fourth quarter of 2015 were $527 million, an increase of $58 million, or 12.4%, compared to the same period in 2014. The increase included the negative year-over-year impact of the 53rd week of $31 million. Excluding the 53rd week, sales increased by $89 million, or 20.3% and included the positive impact of foreign currency translation of approximately 10.3%. Excluding the impact of foreign currency translation and the 53rd week, sales increased by 10.0% primarily due to the combined positive impact of pricing and changes in sales mix, and an increase in volumes.
Adjusted EBITDA(1) Weston Foods adjusted EBITDA(1) in the fourth quarter of 2015 was $67 million, a decrease of $7 million compared to the same period in 2014. The decrease included the negative year-over-year impact of the 53rd week of $6 million. Excluding the 53rd week, adjusted EBITDA(1) decreased by $1 million. Despite the increase in sales, adjusted EBITDA(1) declined primarily due to higher input costs, new plant costs and investments in the business.
Adjusted EBITDA margin(1) in the fourth quarter of 2015 was 12.7% compared to 15.8% in the same period in 2014. The decline in adjusted EBITDA margin(1) in the fourth quarter of 2015 was due to the factors impacting adjusted EBITDA(1), as described above.
Depreciation and Amortization Weston Foods depreciation and amortization was $25 million in the fourth quarter of 2015, an increase of $8 million compared to 2014. Depreciation and amortization included $6 million (2014 - nil) of accelerated depreciation related to the planned closures of cake manufacturing facilities approved in 2015. Excluding this amount, the increase in the fourth quarter of 2015 was $2 million and was due to investments in capital.
Weston Foods Other Business Matters
Restructuring Weston Foods continuously evaluates strategic and cost reduction initiatives related to its manufacturing assets, distribution networks and administrative infrastructure with the objective of ensuring a low cost operating structure. Restructuring activities related to these initiatives are ongoing and in 2015, Weston Foods recorded restructuring and other charges in the fourth quarter of 2015 and year-to-date of $8 million (2014 - $2 million) and $26 million (2014 - $7 million), including $6 million (2014 - nil) and $11 million (2014 - nil) of accelerated depreciation, respectively. These charges primarily relate to restructuring plans approved in 2015 to close three cake manufacturing facilities in Canada and the United States ("U.S."). Weston Foods expects that these closures will be completed by the end of the second quarter of 2016 with production transferring to other facilities.
Loblaw Segment Results | |||||||||||||||||
(unaudited) | Quarters | Ended | Years | Ended | |||||||||||||
($ millions except where otherwise indicated) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | Change | (52 weeks) | (53 weeks) | Change | |||||||||||
Sales | $ | 10,865 | $ | 11,413 | (4.8)% | $ | 45,394 | $ | 42,611 | 6.5% | |||||||
Sales excluding 53rd week | $ | 10,865 | $ | 10,624 | 2.3% | $ | 45,394 | $ | 41,822 | 8.5% | |||||||
Retail gross profit(i) | $ | 2,794 | $ | 2,925 | (4.5)% | $ | 11,689 | $ | 9,734 | 20.1% | |||||||
Retail gross profit(i) excluding 53rd week | $ | 2,794 | $ | 2,725 | 2.5% | $ | 11,689 | $ | 9,534 | 22.6% | |||||||
Adjusted EBITDA(1) | $ | 879 | $ | 948 | (7.3)% | $ | 3,541 | $ | 3,219 | 10.0% | |||||||
Adjusted EBITDA(1) excluding 53rd week | $ | 879 | $ | 877 | 0.2% | $ | 3,541 | $ | 3,148 | 12.5% | |||||||
Adjusted EBITDA margin(1) | 8.1% | 8.3% | 7.8% | 7.6% | |||||||||||||
Depreciation and amortization(ii) | $ | 376 | $ | 393 | (4.3)% | $ | 1,592 | $ | 1,472 | 8.2% | |||||||
(i) |
Retail gross profit includes a charge of $46 million related to the
impairment of drug retail ancillary assets held for sale and a charge of $4 million related to inventory measurement and other conversion differences for Loblaw's franchise grocery stores in the fourth quarter of 2015. Retail gross profit includes a charge of $69 million in the fourth quarter of 2014 related to the recognition of the fair value increment on the acquired Shoppers Drug Mart inventory sold. |
(ii) |
Depreciation and amortization includes $124 million (2014 -
$124 million) in the fourth quarter of 2015 and $536 million (2014 - $417 million) year-to-date of amortization of intangible assets acquired with Shoppers Drug Mart. |
Sales Loblaw sales in the fourth quarter of 2015 were $10,865 million, a decrease of $548 million compared to the same period in 2014, primarily driven by Retail. The decrease in Retail sales included the negative year-over-year impact of the 53rd week of $789 million. Excluding the 53rd week, Retail sales increased by $231 million, or 2.2%, compared to the same period in 2014 and included food retail sales of $7,631 million (2014 - $7,536 million) and drug retail sales of $2,975 million (2014 - $2,839 million).
The increase in Retail sales on a comparable 12 week basis was primarily due to the following factors:
In 2014, Loblaw modified its fee arrangements with the franchisees of certain franchise banners. The modified arrangements resulted in an annual reduction of food retail sales and gross profit, with a corresponding decrease in selling, general and administrative expenses ("SG&A"). In the fourth quarter of 2015, the modified arrangements had a negative impact of $32 million to food retail sales and gross profit, with an offsetting positive impact to SG&A. In 2016, Loblaw will implement these modified fee arrangements with the remaining franchise banners. In 2016, the incremental annual impact of modified fee arrangements to the remaining franchise banners is expected to result in a negative impact to food retail sales and gross profit of approximately $60 million, with an offsetting positive impact to SG&A.
Retail Gross Profit Loblaw Retail gross profit in the fourth quarter of 2015 was $2,794 million, a decrease of $131 million compared to the same period in 2014. The decrease included the negative year-over-year impact of the 53rd week of $200 million. Excluding the 53rd week, Retail gross profit increased $69 million and included the favourable year-over-year net impact of the following items:
Excluding the 53rd week and the favourable year-over-year net impact of the items noted above, Retail gross profit increased $50 million compared to the same period in 2014. Retail gross profit percentage of 26.8% decreased by 10 basis points in the fourth quarter of 2015, and was impacted by:
Excluding these impacts, Retail gross profit percentage decreased 10 basis points and included the following:
Adjusted EBITDA(1) Loblaw adjusted EBITDA(1) in the fourth quarter of 2015 was $879 million, a decrease of $69 million compared to the same period in 2014. The decrease included the negative year-over-year impact of the 53rd week of $71 million. Excluding the 53rd week, adjusted EBITDA(1) increased $2 million and included an increase in adjusted EBITDA(1) at Choice Properties Real Estate Investment Trust ("Choice Properties") (net of intersegment eliminations) partially offset by a decline in Retail adjusted EBITDA(1). Retail adjusted EBITDA(1) decreased $3 million driven by an increase in SG&A of $53 million, or 10 basis points, partially offset by an increase in Retail gross profit, as described above. As a percentage of sales, the increase in SG&A was impacted by the following:
Excluding these impacts, as a percentage of sales, SG&A was essentially flat compared to the same period in 2014 and included the following:
Depreciation and Amortization Loblaw's depreciation and amortization was $376 million in the fourth quarter of 2015, a decrease of $17 million compared to the same period in 2014, and included $124 million (2014 - $124 million) of amortization of intangible assets related to the acquisition of Shoppers Drug Mart. The decline in depreciation and amortization was driven by:
Loblaw Other Business Matters
Impairment of Drug Retail Ancillary Assets Held for Sale During 2015, Loblaw commenced actively marketing the sale of certain assets of its Shoppers ancillary healthcare businesses. As a result, Loblaw recorded a charge of $112 million in the fourth quarter of 2015 associated with the write-down of the assets and other related restructuring charges. Of the $112 million charge, $46 million was recognized in Retail gross profit and the remainder in Retail SG&A. Subsequent to the end of 2015, Loblaw signed an agreement for the sale of certain of these assets. Loblaw expects the annualized impact of the divestitures to be a decrease in Retail sales of approximately $245 million and an increase in operating income of $14 million.
Inventory Measurement As of the end of 2015, Loblaw had completed the conversion of all of its franchised grocery stores to a new IT system that includes a perpetual inventory system. The remeasurement of inventory owned by the franchises as a result of implementing the system resulted in a decrease in inventory value of $33 million in the fourth quarter of 2015. The remeasurement resulted in a charge of $4 million in Retail gross profit related to consolidated franchises and $29 million to Retail SG&A related to non-consolidated franchises.
Consolidation of Franchises In 2015, Loblaw implemented a new, simplified franchise agreement ("Franchise Agreement") for its franchised food retail stores. For financial reporting purposes, the franchise stores subject to the Franchise Agreement were consolidated. All new franchises will be subject to the Franchise Agreement. Existing franchises will be converted to the Franchise Agreement as their existing agreements expire. As at year end 2015, 85 franchises were consolidated and the impacts of the consolidation were as follows:
(unaudited) | 2015 | 2015 | ||||||
(millions of Canadian dollars) | (12 weeks) | (52 weeks) | ||||||
Sales | $ | 28 | $ | 56 | ||||
Retail gross profit | 32 | 58 | ||||||
Adjusted EBITDA(1) | (4) | (12) | ||||||
Depreciation and amortization | 3 | 5 | ||||||
Net loss attributable to Non-Controlling Interest | (3) | (9) |
Loblaw expects that the impact in 2016 of new and current consolidated franchises will be incremental Retail sales of approximately $320 million, an increase to adjusted EBITDA(1) of approximately $40 million and an increase in depreciation and amortization of approximately $20 million.
Closure of Certain Unprofitable Retail Locations In 2015, Loblaw finalized a plan that will result in the closure of 52 unprofitable retail locations across a range of banners and formats. Loblaw expects that the closures will be completed by the end of the second quarter of 2016. On an annualized basis, the closures will decrease sales by approximately $300 million but will result in a favourable impact of approximately $30 million to operating income and $5 million to depreciation and amortization.
The restructuring and other related costs associated with the plan are expected to total approximately $133 million. Loblaw recorded a recovery of $7 million in the fourth quarter of 2015 and a charge of $124 million year-to-date. The charge included $92 million for severance and lease termination costs and $39 million for asset impairments associated with these retail locations. Loblaw expects approximately $9 million to be recognized as the remaining stores close.
During 2015, 33 of the 52 planned Loblaw retail locations were closed.
Accelerated Finalization of Labour Agreements Over the past five years, Loblaw has been transitioning stores to more cost effective and efficient operating terms under Labour Agreements. Loblaw was committed to the transition and accordingly accelerated the finalization of these Labour Agreements for the majority of the remaining stores in the fourth quarter of 2015. Loblaw incurred a charge of approximately $55 million in Retail SG&A related to the completion of this process in the fourth quarter of 2015.
OUTLOOK(2)
Weston Foods expects sales growth generated by new capacity and productivity improvements to drive an increase in adjusted EBITDA(1) in 2016 when compared to 2015. The increase in adjusted EBITDA(1) is expected to be greater in the second half of the year as new plant capacity and capability come on-line. Depreciation is projected to increase in 2016 when compared to 2015, and largely offset the improvement in adjusted EBITDA(1). Management expects to make capital investments of approximately $300 million in 2016.
Loblaw remains focused on its strategic framework, delivering the best in food, best in health and beauty, operational excellence and growth. This strategic framework is supported by a financial strategy of maintaining a stable trading environment that targets positive same-store sales and stable gross margin; surfacing efficiencies; delivering synergies as a result of its acquisition of Shoppers Drug Mart; and returning capital to shareholders. In 2016, Loblaw expects to:
For 2016, the Company expects growth in net earnings to be driven by an increase in net earnings at Loblaw, and the positive impact of the Company's increased ownership in Loblaw as a result of Loblaw's share repurchases.
DECLARATION OF QUARTERLY DIVIDENDS
Subsequent to the end of the fourth quarter of 2015, the Company's Board
of Directors declared a quarterly dividend on GWL Common Shares,
Preferred Shares, Series I, Preferred Shares, Series III, Preferred
Shares, Series IV and Preferred Shares, Series V payable as follows:
Common Shares |
$0.425 per share payable April 1, 2016, to shareholders of record March 15, 2016; |
|||||
Preferred Shares, Series I |
$0.3625 per share payable March 15, 2016, to shareholders of record February 29, 2016; |
|||||
Preferred Shares, Series III |
$0.3250 per share payable April 1, 2016, to shareholders of record March 15, 2016; |
|||||
Preferred Shares, Series IV |
$0.3250 per share payable April 1, 2016, to shareholders of record March 15, 2016; and |
|||||
Preferred Shares, Series V |
$0.296875 per share payable April 1, 2016, to shareholders of record March 15, 2016. |
|||||
NON-GAAP FINANCIAL MEASURES
The Company uses the following non-GAAP financial measures: EBITDA,
adjusted EBITDA and adjusted EBITDA margin, adjusted net earnings
attributable to shareholders of the Company, adjusted net earnings
available to common shareholders of the Company and adjusted basic net
earnings per common share. In addition to these items, the following
measures are used by management in calculating adjusted basic net
earnings per common share: adjusted net interest expense and other
financing charges, adjusted income taxes and adjusted income tax rate.
The Company believes these non-GAAP financial measures provide useful
information to both management and investors in measuring the financial
performance of the Company for the reasons outlined below.
Management uses these and other non-GAAP financial measures to exclude the impact of certain expenses and income that must be recognized under GAAP when analyzing consolidated and segment underlying operating performance. The excluded items are not necessarily reflective of the Company's underlying operating performance and make comparisons of underlying financial performance between periods difficult. From time to time, the Company may exclude additional items if it believes doing so would result in a more effective analysis of underlying operating performance. The exclusion of certain items does not imply that they are non-recurring.
During 2015, management no longer excludes Choice Properties' general and administrative costs in the calculation of certain non-GAAP financial measures when analyzing consolidated and segment underlying operating performance.
These measures do not have a standardized meaning prescribed by GAAP and therefore they may not be comparable to similarly titled measures presented by other publicly traded companies, and they should not be construed as an alternative to other financial measures determined in accordance with GAAP.
For details on the nature of items excluded in the calculation of any of the non-GAAP financial measures detailed below, see Section 19, "Non-GAAP Financial Measures", of the Company's 2015 Annual Report.
EBITDA and Adjusted EBITDA The Company believes adjusted EBITDA is useful in assessing and making decisions regarding the underlying operating performance of the Company's ongoing operations and in assessing the Company's ability to generate cash flows to fund its cash requirements, including its capital investment program and debt reduction objectives.
The following table reconciles EBITDA and adjusted EBITDA to operating income, which is reconciled to GAAP net earnings attributable to shareholders of the Company reported for the periods ended as indicated.
Quarters | Ended | ||||||||||||||||||||||||||
Dec. 31, 2015 | Dec. 31, 2014 | ||||||||||||||||||||||||||
(12 weeks) | (13 weeks) | ||||||||||||||||||||||||||
(unaudited) ($ millions) |
Weston Foods |
Loblaw | Other(i) | Consolidated |
Weston Foods |
Loblaw | Other(i) | Consolidated | |||||||||||||||||||
Net earnings attributable to shareholders of | |||||||||||||||||||||||||||
the Company | $ | 148 | $ | 161 | |||||||||||||||||||||||
Add impact of the following: | |||||||||||||||||||||||||||
Non-controlling interests | 68 | 135 | |||||||||||||||||||||||||
Income taxes | 66 | 95 | |||||||||||||||||||||||||
Net interest expense and other | |||||||||||||||||||||||||||
financing charges | 139 | 231 | |||||||||||||||||||||||||
Operating income | $ | 42 | $ | 314 | $ | 65 | $ | 421 | $ | 74 | $ | 505 | $ | 43 | $ | 622 | |||||||||||
Depreciation and amortization | 25 | 376 | 401 | 17 | 393 | 410 | |||||||||||||||||||||
EBITDA | $ | 67 | $ | 690 | $ | 65 | $ | 822 | $ | 91 | $ | 898 | $ | 43 | $ | 1,032 | |||||||||||
Operating income | $ | 42 | $ | 314 | $ | 65 | $ | 421 | $ | 74 | $ | 505 | $ | 43 | $ | 622 | |||||||||||
Add impact of the following: | |||||||||||||||||||||||||||
Amortization of intangible assets acquired | |||||||||||||||||||||||||||
with Shoppers Drug Mart | 124 | 124 | 124 | 124 | |||||||||||||||||||||||
Restructuring and other charges | 8 | (7) | 1 | 2 | 2 | ||||||||||||||||||||||
Impairment of drug retail ancillary assets | |||||||||||||||||||||||||||
held for sale | 112 | 112 | |||||||||||||||||||||||||
Accelerated finalization of Labour Agreements | 55 | 55 | |||||||||||||||||||||||||
Charge related to inventory measurement | |||||||||||||||||||||||||||
and other conversion differences | 33 | 33 | |||||||||||||||||||||||||
Fixed asset and other related impairments, | |||||||||||||||||||||||||||
net of recoveries | 4 | 4 | 1 | 1 | |||||||||||||||||||||||
Pension annuities and buy-outs | 3 | 6 | 9 | ||||||||||||||||||||||||
Shoppers Drug Mart net divestitures | |||||||||||||||||||||||||||
and acquisition costs | 14 | 14 | |||||||||||||||||||||||||
Modifications to certain franchise fee | |||||||||||||||||||||||||||
arrangements | (8) | (8) | (40) | (40) | |||||||||||||||||||||||
Fair value adjustment of derivatives | (5) | (6) | (11) | (7) | 4 | (3) | |||||||||||||||||||||
Recognition of fair value increment | |||||||||||||||||||||||||||
on inventory sold | 69 | 69 | |||||||||||||||||||||||||
Fair value adjustment of Shoppers Drug | |||||||||||||||||||||||||||
Mart's share-based compensation liability | 2 | 2 | |||||||||||||||||||||||||
Net insurance proceeds | (12) | (12) | |||||||||||||||||||||||||
Foreign currency translation | (65) | (65) | (43) | (43) | |||||||||||||||||||||||
Adjusted operating income | $ | 48 | $ | 627 | $ | 675 | $ | 57 | $ | 679 | $ | 736 | |||||||||||||||
Depreciation and amortization excluding the | |||||||||||||||||||||||||||
impact of the above adjustments(ii) | 19 | 252 | 271 | 17 | 269 | 286 | |||||||||||||||||||||
Adjusted EBITDA | $ | 67 | $ | 879 | $ | 946 | $ | 74 | $ | 948 | $ | 1,022 | |||||||||||||||
(i) |
Represents the effect of foreign currency translation on a portion of
the U.S. dollar denominated cash and cash equivalents and short term investments held by foreign operations. |
(ii) |
Depreciation and amortization for the calculation of adjusted EBITDA
excludes $124 million (2014 - $124 million) of amortization of intangible assets, acquired with Shoppers Drug Mart, recorded by Loblaw and $6 million (2014 - nil) of accelerated depreciation recorded by Weston Foods, related to restructuring and other charges. |
Years | Ended | |||||||||||||||||||||||||
Dec. 31, 2015 | Dec. 31, 2014 | |||||||||||||||||||||||||
(52 weeks) | (53 weeks) | |||||||||||||||||||||||||
(unaudited) ($ millions) |
Weston Foods |
Loblaw | Other(i) | Consolidated |
Weston Foods |
Loblaw | Other(i) | Consolidated | ||||||||||||||||||
Net earnings attributable to shareholders | ||||||||||||||||||||||||||
of the Company | $ | 527 | $ | 126 | ||||||||||||||||||||||
Add impact of the following: | ||||||||||||||||||||||||||
Non-controlling interests | 337 | 8 | ||||||||||||||||||||||||
Income taxes | 384 | 24 | ||||||||||||||||||||||||
Net interest expense and other | ||||||||||||||||||||||||||
financing charges | 681 | 815 | ||||||||||||||||||||||||
Operating income | $ | 177 | $ | 1,593 | $ | 159 | $ | 1,929 | $ | 231 | $ | 654 | $ | 88 | $ | 973 | ||||||||||
Depreciation and amortization | 94 | 1,592 | 1,686 | 70 | 1,472 | 1,542 | ||||||||||||||||||||
EBITDA | $ | 271 | $ | 3,185 | $ | 159 | $ | 3,615 | $ | 301 | $ | 2,126 | $ | 88 | $ | 2,515 | ||||||||||
Operating income | $ | 177 | $ | 1,593 | $ | 159 | $ | 1,929 | $ | 231 | $ | 654 | $ | 88 | $ | 973 | ||||||||||
Add impact of the following: | ||||||||||||||||||||||||||
Amortization of intangible assets acquired | ||||||||||||||||||||||||||
with Shoppers Drug Mart | 536 | 536 | 417 | 417 | ||||||||||||||||||||||
Restructuring and other charges | 26 | 154 | 180 | 7 | 46 | 53 | ||||||||||||||||||||
Impairment of drug retail ancillary assets | ||||||||||||||||||||||||||
held for sale | 112 | 112 | ||||||||||||||||||||||||
Accelerated finalization of Labour Agreements | 55 | 55 | ||||||||||||||||||||||||
Charge related to inventory measurement | ||||||||||||||||||||||||||
and other conversion differences | 33 | 33 | 190 | 190 | ||||||||||||||||||||||
Fixed asset and other related impairments, | ||||||||||||||||||||||||||
net of recoveries | 13 | 13 | 16 | 16 | ||||||||||||||||||||||
Charge related to apparel inventory | 8 | 8 | ||||||||||||||||||||||||
Pension annuities and buy-outs | 3 | 8 | 11 | |||||||||||||||||||||||
Shoppers Drug Mart net divestitures | ||||||||||||||||||||||||||
and acquisition costs | 2 | 2 | 72 | 72 | ||||||||||||||||||||||
Modifications to certain franchise fee | ||||||||||||||||||||||||||
arrangements | (8) | (8) | (40) | (40) | ||||||||||||||||||||||
Fair value adjustment of derivatives | (5) | (21) | (26) | (4) | 4 | |||||||||||||||||||||
Recognition of fair value increment | ||||||||||||||||||||||||||
on inventory sold | 798 | 798 | ||||||||||||||||||||||||
Fair value adjustment of Shoppers Drug | ||||||||||||||||||||||||||
Mart's share-based compensation liability | 7 | 7 | ||||||||||||||||||||||||
Inventory loss (net insurance proceeds) | 1 | 1 | (1) | (1) | ||||||||||||||||||||||
Multi-employer pension plan settlement | ||||||||||||||||||||||||||
payment | 8 | 8 | ||||||||||||||||||||||||
Foreign currency translation | (159) | (159) | (88) | (88) | ||||||||||||||||||||||
Adjusted operating income | $ | 202 | $ | 2,485 | $ | 2,687 | $ | 241 | $ | 2,164 | $ | 2,405 | ||||||||||||||
Depreciation and amortization excluding the | ||||||||||||||||||||||||||
impact of the above adjustments(ii) | 83 | 1,056 | 1,139 | 70 | 1,055 | 1,125 | ||||||||||||||||||||
Adjusted EBITDA | $ | 285 | $ | 3,541 | $ | 3,826 | $ | 311 | $ | 3,219 | $ | 3,530 | ||||||||||||||
(i) |
Represents the effect of foreign currency translation on a portion of
the U.S. dollar denominated cash and cash equivalents and short term investments held by foreign operations. |
(ii) |
Depreciation and amortization for the calculation of adjusted EBITDA
excludes $536 million (2014 - $417 million) of amortization of intangible assets, acquired with Shoppers Drug Mart, recorded by Loblaw and $11 million (2014 - nil) of accelerated depreciation recorded by Weston Foods, related to restructuring and other charges. |
Adjusted Net Interest Expense and Other Financing Charges The Company believes adjusted net interest expense and other financing charges is useful in assessing the ongoing net financing costs of the Company.
The following table reconciles adjusted net interest expense and other financing charges to GAAP net interest expense and other financing charges reported for the periods ended as indicated.
Quarters | Ended | Years | Ended | ||||||||||||||||
(unaudited) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |||||||||||||||
($ millions) | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | |||||||||||||||
Net interest expense and other financing charges | $ | 139 | $ | 231 | $ | 681 | $ | 815 | |||||||||||
Add: | Fair value adjustment of the Trust Unit liability | (5) | (14) | (55) | (12) | ||||||||||||||
Fair value adjustment of the forward sale agreement | |||||||||||||||||||
for 9.6 million Loblaw common shares | 9 | (59) | (26) | (199) | |||||||||||||||
Accelerated amortization of deferred financing costs | (5) | (15) | (23) | ||||||||||||||||
Shoppers Drug Mart net financing charges | (15) | ||||||||||||||||||
Adjusted net interest expense and other financing charges | $ | 143 | $ | 153 | $ | 585 | $ | 566 | |||||||||||
Adjusted Income Taxes and Adjusted Income Tax Rate The Company believes the adjusted income tax rate applicable to adjusted earnings before taxes is useful in assessing the underlying operating performance of its business.
The following table reconciles the effective income tax rate applicable to adjusted earnings before taxes to the GAAP effective income tax rate applicable to earnings before taxes as reported for the periods ended as indicated.
Quarters | Ended | Years | Ended | |||||||||||
(unaudited) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | ||||||||||
($ millions except where otherwise indicated) | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | ||||||||||
Adjusted operating income(i) | $ | 675 | $ | 736 | $ | 2,687 | $ | 2,405 | ||||||
Adjusted net interest expense and other financing charges(i) | 143 | 153 | 585 | 566 | ||||||||||
Adjusted earnings before taxes | $ | 532 | $ | 583 | $ | 2,102 | $ | 1,839 | ||||||
Income taxes | $ | 66 | $ | 95 | $ | 384 | $ | 24 | ||||||
Add: | Tax impact of items excluded from adjusted earnings before taxes(ii) | 78 | 60 | 232 | 455 | |||||||||
Provincial income tax rate change | (45) | |||||||||||||
Adjusted income taxes | $ | 144 | $ | 155 | $ | 571 | $ | 479 | ||||||
Effective income tax rate applicable to earnings before taxes | 23.4% | 24.3% | 30.8% | 15.2% | ||||||||||
Adjusted income tax rate applicable to adjusted earnings before taxes | 27.1% | 26.6% | 27.2% | 26.0% | ||||||||||
(i) | See reconciliations of adjusted operating income and adjusted net interest expense and other financing charges above. |
(ii) |
See the EBITDA and adjusted EBITDA table and the adjusted net interest
expense and other financing charges table above for a complete list of items excluded from adjusted earnings before taxes. |
Adjusted Basic Net Earnings per Common Share and Adjusted Net Earnings The Company believes adjusted basic net earnings per common share and adjusted net earnings are useful in assessing the Company's underlying operating performance and in making decisions regarding the ongoing operations of its business.
The following table reconciles adjusted basic net earnings per common share and adjusted net earnings to GAAP basic net earnings per common share reported for the periods ended as indicated.
Quarters | Ended | Years | Ended | |||||||||||||||||||
(unaudited) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | ||||||||||||||||||
($ except where otherwise indicated) | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | ||||||||||||||||||
Basic net earnings per common share | $ | 1.08 | $ | 1.18 | $ | 3.78 | $ | 0.64 | ||||||||||||||
Add impact of the following(i): | ||||||||||||||||||||||
Amortization of intangible assets acquired | ||||||||||||||||||||||
with Shoppers Drug Mart | 0.32 | 0.33 | 1.40 | 1.09 | ||||||||||||||||||
Restructuring and other charges | 0.01 | 0.01 | 0.58 | 0.17 | ||||||||||||||||||
Impairment of drug retail ancillary assets | ||||||||||||||||||||||
held for sale | 0.28 | 0.28 | ||||||||||||||||||||
Accelerated finalization of Labour Agreements | 0.14 | 0.14 | ||||||||||||||||||||
Charge related to inventory measurement and | ||||||||||||||||||||||
other conversion differences | 0.09 | 0.09 | 0.49 | |||||||||||||||||||
Pension annuities and buy-outs | 0.04 | 0.04 | ||||||||||||||||||||
Fixed asset and other related impairments, | ||||||||||||||||||||||
net of recoveries | 0.02 | 0.04 | 0.05 | |||||||||||||||||||
Charge related to apparel inventory | 0.02 | |||||||||||||||||||||
Shoppers Drug Mart net divestitures and | ||||||||||||||||||||||
acquisition costs | 0.04 | 0.01 | 0.29 | |||||||||||||||||||
Modifications to certain franchise fee arrangements | (0.03) | (0.11) | (0.03) | (0.11) | ||||||||||||||||||
Fair value adjustment of derivatives | (0.04) | (0.03) | (0.08) | (0.01) | ||||||||||||||||||
Recognition of fair value increment on inventory sold | 0.17 | 2.08 | ||||||||||||||||||||
Fair value adjustment of Shoppers Drug | ||||||||||||||||||||||
Mart's share-based compensation liability | 0.02 | |||||||||||||||||||||
Inventory loss (net insurance proceeds) | (0.06) | 0.01 | (0.01) | |||||||||||||||||||
MEPP settlement payment | 0.04 | |||||||||||||||||||||
Fair value adjustment of the forward sale agreement | ||||||||||||||||||||||
for 9.6 million Loblaw common shares | (0.05) | 0.35 | 0.15 | 1.17 | ||||||||||||||||||
Fair value adjustment of the Trust Unit liability | 0.01 | 0.03 | 0.09 | 0.04 | ||||||||||||||||||
Accelerated amortization of deferred financing costs | 0.01 | 0.04 | 0.06 | |||||||||||||||||||
Provincial income tax rate change | 0.19 | |||||||||||||||||||||
Foreign currency translation | (0.44) | (0.34) | (1.14) | (0.69) | ||||||||||||||||||
Adjusted basic net earnings per common share | $ | 1.43 | $ | 1.58 | $ | 5.61 | $ | 5.32 | ||||||||||||||
Weighted average common shares outstanding (millions) | 127.6 | 127.7 | 127.7 | 127.8 | ||||||||||||||||||
Adjusted net earnings attributable to shareholders of | ||||||||||||||||||||||
the Company ($ millions) | $ | 193 | $ | 212 | $ | 761 | $ | 724 | ||||||||||||||
Prescribed dividends on preferred shares in share | ||||||||||||||||||||||
capital ($ millions) | 10 | 10 | 44 | 44 | ||||||||||||||||||
Adjusted net earnings available to common | ||||||||||||||||||||||
shareholders of the Company ($ millions) | $ | 183 | $ | 202 | $ | 717 | $ | 680 | ||||||||||||||
(i) | Net of income taxes and non-controlling interests, as applicable. |
FORWARD-LOOKING STATEMENTS
This News Release contains forward-looking statements about the
Company's objectives, plans, goals, aspirations, strategies, financial
condition, results of operations, cash flows, performance, prospects
and opportunities. Specific forward-looking statements in this News
Release include, but are not limited to, statements with respect to the
Company's anticipated future results, events and plans, synergies and
other anticipated benefits associated with the acquisition of Shoppers
Drug Mart, and planned capital investments. These specific
forward-looking statements are contained throughout this News Release
including, without limitation, in the "Outlook" section of this News
Release. Forward-looking statements are typically identified by words
such as "expect", "anticipate", "believe", "foresee", "could",
"estimate", "goal", "intend", "plan", "seek", "strive", "will", "may",
"maintain", "achieve", "grow", and "should" and similar expressions, as
they relate to the Company and its management.
Forward-looking statements reflect the Company's current estimates, beliefs and assumptions, which are based on management's perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. The Company's expectation of operating and financial performance in 2016 is based on certain assumptions including assumptions about sales and volume growth, anticipated cost savings, operating efficiencies, and continued growth from current initiatives. The Company's estimates, beliefs and assumptions are inherently subject to significant business, economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. The Company can give no assurance that such estimates, beliefs and assumptions will prove to be correct.
Numerous risks and uncertainties could cause the Company's actual results to differ materially from those expressed, implied or projected in the forward-looking statements, including those described in Section 13, "Enterprise Risks and Risk Management", of the MD&A in the Company's 2015 Annual Report and the Company's Annual Information Form ("AIF") for the year ended December 31, 2015. Such risks and uncertainties include:
This is not an exhaustive list of the factors that may affect the Company's forward-looking statements. Other risks and uncertainties not presently known to the Company or that the Company presently believes are not material could also cause actual results or events to differ materially from those expressed in its forward-looking statements. Additional risks and uncertainties are discussed in the Company's materials filed with the Canadian securities regulatory authorities from time to time, including without limitation, the section entitled "Operating and Financial Risks and Risk Management" in the Company's AIF for the year ended December 31, 2015. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's expectations only as of the date of this News Release. Except as required by law, the Company does not undertake to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SELECTED FINANCIAL INFORMATION
The following includes selected quarterly financial information which is
prepared by management in accordance with International Financial
Reporting Standards ("IFRS") and is based on the Company's audited
annual consolidated financial statements for the year ended
December 31, 2015. This financial information does not contain all
disclosures required by IFRS, and accordingly, this financial
information should be read in conjunction with the Company's 2015
Annual Report available in the Investor Centre section of the Company's
website at www.weston.ca.
Condensed Consolidated Statements of Earnings
(unaudited) | ||||||||||||||||||||
(millions of Canadian dollars except where otherwise indicated) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | ||||||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | ||||||||||||||||
Revenue | $ | 11,248 | $ | 11,734 | $ | 46,894 | $ | 43,918 | ||||||||||||
Operating Expenses | ||||||||||||||||||||
Cost of inventories sold | 8,046 | 8,423 | 33,667 | 32,727 | ||||||||||||||||
Selling, general and administrative expenses | 2,781 | 2,689 | 11,298 | 10,218 | ||||||||||||||||
10,827 | 11,112 | 44,965 | 42,945 | |||||||||||||||||
Operating Income | 421 | 622 | 1,929 | 973 | ||||||||||||||||
Net Interest Expense and Other Financing Charges | 139 | 231 | 681 | 815 | ||||||||||||||||
Earnings Before Income Taxes | 282 | 391 | 1,248 | 158 | ||||||||||||||||
Income Tax Expense | 66 | 95 | 384 | 24 | ||||||||||||||||
Net Earnings | 216 | 296 | 864 | 134 | ||||||||||||||||
Attributable to: | ||||||||||||||||||||
Shareholders of the Company | 148 | 161 | 527 | 126 | ||||||||||||||||
Non-Controlling Interests | 68 | 135 | 337 | 8 | ||||||||||||||||
Net Earnings | $ | 216 | $ | 296 | $ | 864 | $ | 134 | ||||||||||||
Net Earnings per Common Share ($) | ||||||||||||||||||||
Basic | $ | 1.08 | $ | 1.18 | $ | 3.78 | $ | 0.64 | ||||||||||||
Diluted | $ | 1.08 | $ | 1.17 | $ | 3.74 | $ | 0.64 | ||||||||||||
Condensed Consolidated Balance Sheets
As at December 31 | ||||||||||
(millions of Canadian dollars) | 2015 | 2014(i) | ||||||||
ASSETS | ||||||||||
Current Assets | ||||||||||
Cash and cash equivalents | $ | 1,413 | $ | 1,333 | ||||||
Short term investments | 1,166 | 1,072 | ||||||||
Accounts receivable | 1,478 | 1,318 | ||||||||
Credit card receivables | 2,790 | 2,630 | ||||||||
Inventories | 4,517 | 4,463 | ||||||||
Income taxes recoverable | 30 | |||||||||
Prepaid expenses and other assets | 279 | 223 | ||||||||
Assets held for sale | 71 | 23 | ||||||||
Total Current Assets | 11,714 | 11,092 | ||||||||
Fixed Assets | 11,352 | 10,938 | ||||||||
Investment Properties | 160 | 185 | ||||||||
Intangible Assets | 9,292 | 9,786 | ||||||||
Goodwill | 3,836 | 3,756 | ||||||||
Deferred Income Taxes | 156 | 215 | ||||||||
Security Deposits | 88 | 92 | ||||||||
Franchise Loans Receivable | 329 | 399 | ||||||||
Other Assets | 875 | 683 | ||||||||
Total Assets | $ | 37,802 | $ | 37,146 | ||||||
LIABILITIES | ||||||||||
Current Liabilities | ||||||||||
Bank indebtedness | $ | 143 | $ | 162 | ||||||
Trade payables and other liabilities | 5,381 | 4,934 | ||||||||
Provisions | 180 | 130 | ||||||||
Income taxes payable | 73 | |||||||||
Short term debt | 1,086 | 1,101 | ||||||||
Long term debt due within one year | 1,348 | 420 | ||||||||
Associate interest | 216 | 193 | ||||||||
Capital securities | 225 | |||||||||
Total Current Liabilities | 8,427 | 7,165 | ||||||||
Provisions | 157 | 103 | ||||||||
Long Term Debt | 10,928 | 12,306 | ||||||||
Trust Unit Liability | 552 | 494 | ||||||||
Deferred Income Taxes | 1,990 | 1,980 | ||||||||
Other Liabilities | 818 | 849 | ||||||||
Total Liabilities | 22,872 | 22,897 | ||||||||
EQUITY | ||||||||||
Share Capital | 1,008 | 997 | ||||||||
Contributed Surplus | 19 | 80 | ||||||||
Retained Earnings | 6,441 | 6,125 | ||||||||
Accumulated Other Comprehensive Income | 231 | 87 | ||||||||
Total Equity Attributable to Shareholders of the Company | 7,699 | 7,289 | ||||||||
Non-Controlling Interests | 7,231 | 6,960 | ||||||||
Total Equity | 14,930 | 14,249 | ||||||||
Total Liabilities and Equity | $ | 37,802 | $ | 37,146 | ||||||
(i) |
Certain 2014 figures have been restated. See notes 2 and 5 of the
Company's consolidated financial statements included in the 2015 Annual Report. |
Condensed Consolidated Statements of Cash Flows
(unaudited) | |||||||||||||||||||||
(millions of Canadian dollars) | Dec. 31, 2015 | Dec. 31, 2014(i) | Dec. 31, 2015 | Dec. 31, 2014(i) | |||||||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | |||||||||||||||||
Operating Activities | |||||||||||||||||||||
Net earnings | $ | 216 | $ | 296 | $ | 864 | $ | 134 | |||||||||||||
Add: | |||||||||||||||||||||
Net interest expense and other financing charges | 139 | 231 | 681 | 815 | |||||||||||||||||
Income taxes | 66 | 95 | 384 | 24 | |||||||||||||||||
Depreciation and amortization | 401 | 410 | 1,686 | 1,542 | |||||||||||||||||
Recognition of fair value increment on inventory sold | 69 | 798 | |||||||||||||||||||
Charge related to inventory measurement and other conversion differences | 4 | 4 | 190 | ||||||||||||||||||
Fixed asset and other related impairments | 26 | 1 | 73 | 16 | |||||||||||||||||
Foreign currency translation gain | (65) | (43) | (159) | (88) | |||||||||||||||||
787 | 1,059 | 3,533 | 3,431 | ||||||||||||||||||
Change in credit card receivables | (127) | (81) | (160) | (92) | |||||||||||||||||
Change in non-cash working capital | 158 | 172 | 220 | (319) | |||||||||||||||||
Income taxes paid | (66) | (74) | (263) | (317) | |||||||||||||||||
Interest received | 3 | 4 | 13 | 35 | |||||||||||||||||
Other | (71) | 10 | 24 | 113 | |||||||||||||||||
Cash Flows from Operating Activities | 684 | 1,090 | 3,367 | 2,851 | |||||||||||||||||
Investing Activities | |||||||||||||||||||||
Acquisition of Shoppers Drug Mart Corporation, net of cash acquired | (6,619) | ||||||||||||||||||||
Fixed asset purchases | (421) | (351) | (1,267) | (984) | |||||||||||||||||
Intangible asset additions | (104) | (96) | (233) | (230) | |||||||||||||||||
Cash assumed on initial consolidation of franchises | 33 | 33 | |||||||||||||||||||
Change in short term investments | (19) | (12) | 57 | 502 | |||||||||||||||||
Change in security deposits | 209 | 1 | 10 | 1,704 | |||||||||||||||||
Other | 34 | 8 | (7) | 43 | |||||||||||||||||
Cash Flows used in Investing Activities | (268) | (450) | (1,407) | (5,584) | |||||||||||||||||
Financing Activities | |||||||||||||||||||||
Change in bank indebtedness | (100) | (161) | (19) | (133) | |||||||||||||||||
Change in short term debt | (20) | 11 | (15) | 41 | |||||||||||||||||
Interest paid | (120) | (139) | (587) | (604) | |||||||||||||||||
Redemption of Loblaw capital securities | (225) | ||||||||||||||||||||
Long term debt | - Issued | 338 | 125 | 1,186 | 6,064 | ||||||||||||||||
- Retired | (502) | (341) | (1,783) | (3,536) | |||||||||||||||||
Share capital | - Issued | 1 | 2 | 9 | 21 | ||||||||||||||||
- Purchased and held in trusts | (7) | (11) | |||||||||||||||||||
- Purchased and cancelled | (16) | (14) | (29) | ||||||||||||||||||
Loblaw common share capital | - Issued | 15 | 19 | 63 | 129 | ||||||||||||||||
- Purchased and held in trusts | (6) | (63) | |||||||||||||||||||
- Purchased and cancelled | (186) | (29) | (280) | (178) | |||||||||||||||||
Loblaw preferred share capital | - Issued | 221 | |||||||||||||||||||
Dividends | - To common shareholders | (53) | (162) | (267) | |||||||||||||||||
- To preferred shareholders | (3) | (11) | (36) | (52) | |||||||||||||||||
- To minority shareholders | (57) | (55) | (229) | (273) | |||||||||||||||||
Other | 16 | 26 | 23 | ||||||||||||||||||
Cash Flows (used in) from Financing Activities | (624) | (622) | (1,918) | 1,172 | |||||||||||||||||
Effect of foreign currency exchange rate changes on | |||||||||||||||||||||
cash and cash equivalents | 16 | 11 | 38 | 25 | |||||||||||||||||
Change in Cash and Cash Equivalents | (192) | 29 | 80 | (1,536) | |||||||||||||||||
Cash and Cash Equivalents, Beginning of Period | 1,605 | 1,304 | 1,333 | 2,869 | |||||||||||||||||
Cash and Cash Equivalents, End of Period | $ | 1,413 | $ | 1,333 | $ | 1,413 | $ | 1,333 | |||||||||||||
(i) | Certain 2014 figures have been restated. See note 2 of the Company's consolidated financial statements included in the 2015 Annual Report. |
Basic and Diluted Net Earnings per Common Share
(unaudited) | |||||||||||||||||||
(millions of Canadian dollars except where otherwise indicated) | Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |||||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | |||||||||||||||
Net earnings attributable to shareholders of the Company | $ | 148 | $ | 161 | $ | 527 | $ | 126 | |||||||||||
Prescribed dividends on preferred shares in share capital | (10) | (10) | (44) | (44) | |||||||||||||||
Net earnings available to common shareholders of the Company | $ | 138 | $ | 151 | $ | 483 | $ | 82 | |||||||||||
Reduction in net earnings due to dilution at Loblaw | (1) | (3) | |||||||||||||||||
Net earnings available to common shareholders for diluted earnings per share | $ | 138 | $ | 150 | $ | 480 | $ | 82 | |||||||||||
Weighted average common shares outstanding (in millions) | 127.6 | 127.7 | 127.7 | 127.8 | |||||||||||||||
Dilutive effect of share-based compensation(i) (in millions) | 0.6 | 0.5 | 0.5 | 0.4 | |||||||||||||||
Diluted weighted average common shares outstanding (in millions) | 128.2 | 128.2 | 128.2 | 128.2 | |||||||||||||||
Basic net earnings per common share ($) | $ | 1.08 | $ | 1.18 | $ | 3.78 | $ | 0.64 | |||||||||||
Diluted net earnings per common share ($) | $ | 1.08 | $ | 1.17 | $ | 3.74 | $ | 0.64 | |||||||||||
(i) |
In the fourth quarter of 2015 and year-to-date, 325,817 (2014 - 79,962)
and 347,225 (2014 - 501,963) potentially dilutive instruments, respectively, were excluded from the computation of diluted net earnings per common share as they were anti-dilutive. |
Segment Information
The Company has two reportable operating segments: Weston Foods and Loblaw. The accounting policies of the reportable operating segments are the same as those described herein and in the Company's 2015 audited annual consolidated financial statements. The Company measures each reportable operating segment's performance based on adjusted EBITDA(1) and adjusted operating income(1). Neither reportable operating segment is reliant on any single external customer.
(unaudited) | ||||||||||||||||||||
(millions of Canadian dollars) | Dec. 31, 2015 | Dec. 31, 2014(i) | Dec. 31, 2015 | Dec. 31, 2014(i) | ||||||||||||||||
For the periods ended as indicated | (12 weeks) | (13 weeks) | (52 weeks) | (53 weeks) | ||||||||||||||||
Revenue | ||||||||||||||||||||
Weston Foods | $ | 527 | $ | 469 | $ | 2,144 | $ | 1,923 | ||||||||||||
Loblaw | 10,865 | 11,413 | 45,394 | 42,611 | ||||||||||||||||
Intersegment | (144) | (148) | (644) | (616) | ||||||||||||||||
Consolidated | $ | 11,248 | $ | 11,734 | $ | 46,894 | $ | 43,918 | ||||||||||||
Adjusted EBITDA(ii) | ||||||||||||||||||||
Weston Foods | $ | 67 | $ | 74 | $ | 285 | $ | 311 | ||||||||||||
Loblaw | 879 | 948 | 3,541 | 3,219 | ||||||||||||||||
Total | $ | 946 | $ | 1,022 | $ | 3,826 | $ | 3,530 | ||||||||||||
Depreciation and Amortization(iii) | ||||||||||||||||||||
Weston Foods | $ | 19 | $ | 17 | $ | 83 | $ | 70 | ||||||||||||
Loblaw | 252 | 269 | 1,056 | 1,055 | ||||||||||||||||
Total | $ | 271 | $ | 286 | $ | 1,139 | $ | 1,125 | ||||||||||||
Adjusted Operating Income(ii) | ||||||||||||||||||||
Weston Foods | $ | 48 | $ | 57 | $ | 202 | $ | 241 | ||||||||||||
Loblaw | 627 | 679 | 2,485 | 2,164 | ||||||||||||||||
Impact of certain items(iv) | (319) | (157) | (917) | (1,520) | ||||||||||||||||
Other(v) | 65 | 43 | 159 | 88 | ||||||||||||||||
Consolidated operating income | $ | 421 | $ | 622 | $ | 1,929 | $ | 973 | ||||||||||||
Net Interest Expense and Other Financing Charges | ||||||||||||||||||||
Weston Foods | $ | 3 | $ | 72 | $ | 77 | $ | 250 | ||||||||||||
Loblaw | 141 | 169 | 644 | 584 | ||||||||||||||||
Other(vi) | (3) | (4) | (14) | (14) | ||||||||||||||||
Intersegment(vii) | (2) | (6) | (26) | (5) | ||||||||||||||||
Consolidated net interest expense and other financing charges | $ | 139 | $ | 231 | $ | 681 | $ | 815 | ||||||||||||
(i) | Certain 2014 figures have been amended. |
(ii) | Excludes certain items and is used internally by management when analyzing segment underlying operating performance. |
(iii) |
Excludes $124 million (2014 - $124 million) and $536 million (2014 -
$417 million), respectively, of amortization of intangible assets, acquired with Shoppers Drug Mart, recorded by Loblaw and $6 million (2014 - nil) and $11 million (2014 - nil), respectively, of accelerated depreciation recorded by Weston Foods, included in restructuring and other charges, in the fourth quarter of 2015 and year-to-date. |
(iv) |
The impact of certain items excluded by management includes
restructuring and other charges, impairment of drug retail ancillary assets held for sale at Loblaw, a charge related to labour agreements at Loblaw, a charge related to the change in inventory measurement and other conversion differences at Loblaw, fixed asset and other related impairments, net of recoveries, at Loblaw, a charge related to apparel inventory at Loblaw, charges related to pension annuities and buy-outs, certain charges related to the acquisition of Shoppers Drug Mart, modifications to certain franchise fee arrangements at Loblaw, the fair value adjustment of derivatives, fair value adjustment of Shoppers Drug Mart's share-based compensation liability at Loblaw, inventory loss incurred (net insurance proceeds received) by Weston Foods and MEPP settlement payment by Weston Foods. |
(v) |
Represents the effect of foreign currency translation on a portion of
the U.S. dollar denominated cash and cash equivalents and short term investments held by foreign operations. |
(vi) | Represents the Trust Unit distributions from Choice Properties to GWL. |
(vii) |
Represents the elimination of the fair value adjustment of the Trust
Unit liability related to GWL's direct investment in Choice Properties. |
2015 ANNUAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND MANAGEMENT'S
DISCUSSION AND ANALYSIS
The Company's annual audited consolidated financial statements and MD&A
for the year ended December 31, 2015 are available in the Investor
Centre section of the Company's website at www.weston.ca and have been
filed with SEDAR and are available online at www.sedar.com.
INVESTOR RELATIONS
Shareholders, security analysts and investment professionals should
direct their requests to Mr. Geoffrey H. Wilson, Senior Vice President,
Investor Relations, Business Intelligence and Communications, at the
Company's Executive Office or by e-mail at [email protected].
Additional financial information has been filed electronically with various securities regulators in Canada through SEDAR. This News Release includes selected information on Loblaw Companies Limited, a public company with shares trading on the Toronto Stock Exchange. For information regarding Loblaw, readers should also refer to the materials filed by Loblaw with SEDAR from time to time. These filings are also maintained at Loblaw's corporate website at www.loblaw.ca.
CONFERENCE CALL AND WEBCAST PRESENTATION
George Weston Limited will host a conference call as well as an audio
webcast on Thursday, March 3, 2016 at 9:00 a.m. (EST). To access via
tele-conference, please dial (647) 427-7450. The playback will be
available two hours after the event at (416) 849-0833, passcode:
24832484#. To access via audio webcast, please visit the Investor
Centre section of www.weston.ca. Pre-registration will be available.
ANNUAL MEETING
The George Weston Limited Annual Meeting of Shareholders will be held on
Tuesday, May 10, 2016, at 11:00 a.m. (EST) at The Royal Conservatory,
TELUS Centre for Performance and Learning, Koerner Hall,
273 Bloor Street West, Toronto, Ontario, Canada.
Endnotes | |
(1) | See "Non-GAAP Financial Measures" section of this News Release. |
(2) | This News Release contains forward-looking information. See Forward-Looking Statements of this News Release for a discussion of material factors that could cause actual results to differ materially from the forecasts and projections herein and of the material factors, estimates, beliefs and assumptions that were applied in presenting the conclusions, forecasts and projections presented herein. This News Release must be read in conjunction with GWL's filings with securities regulators made from time to time, all of which can be found at www.weston.ca and www.sedar.com. |
SOURCE George Weston Limited